Shares of BP p.l.c. BP rose sharply in pre-market trading.
The Wall Street Journal reported Sunday that Elliott Management has built a stake in BP and will push for transformational changes.
BP shares jumped 6% to $34.20 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Patriot National Bancorp, Inc. PNBK gained 70.6% to $2.44 in pre-market trading after falling over 3% on Friday.
- Starbox Group Holdings Ltd. STBX rose 51% to $0.5020 in pre-market trading after falling around 4% on Friday.
- MGO Global, Inc. MGOL gained 43.3% to $0.5953 in pre-market trading after jumping 124% on Friday.
- Cyngn Inc. CYN gained 32.1% to $0.0795 in pre-market trading after dipping over 28% on Friday.
- Yoshiharu Global Co. YOSH shares jumped 24.4% to $8.20 in pre-market trading after jumping 34% on Friday.
- Microbot Medical Inc. MBOT gained 20% to $3.06 after surging around 18% on Friday.
- Solid Biosciences Inc. SLDB shares climbed 19.1% to $3.43 in pre-market trading after dipping 8% on Friday.
- Satellogic Inc. SATL gained 13.6% to $4.19 in pre-market trading after climbing 10% on Friday.
- Century Aluminum Company CENX gained 9.4% to $20.44 in pre-market.
Losers
- Fennec Pharmaceuticals Inc. FENC shares fell 54.8% to $3.00 in pre-market trading.
- Pliant Therapeutics, Inc. PLRX dipped 54.5% to $3.54 in pre-market trading after the company issued an update on BEACON-IPF, a Phase 2b/3 trial in patients with idiopathic pulmonary fibrosis.
- Mynaric AG MYNA fell 32.7% to $0.2550 in today's pre-market trading after gaining over 11% on Friday.
- PS International Group Ltd. PSIG shares fell 25.4% to $0.4701 in pre-market trading after gaining 5% on Friday.
- Semtech Corporation SMTC shares tumbled 25.2% to $40.75 in pre-market trading. Semtech shares fell around 10% on Friday after Baird cut its price target on the stock from $80 to $60.
- Oriental Rise Holdings Limited ORIS declined 20.2% to $0.91 in pre-market trading after falling more than 5% on Friday.
- Replimune Group, Inc. REPL fell 19.6% to $11.21 in pre-market trading. Replimune announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
- Maze Therapeutics, Inc. MAZE fell 9.5% to $12.11 in pre-market trading. Maze Therapeutics shares gained around 3% on Friday after the company announced that the first patient has been dosed in the company’s Phase 2 clinical trial, the HORIZON Study, of MZE829 in patients with APOL1 kidney disease.
- Dogness (International) Corporation DOGZ fell 6.6% to $33.00 in pre-market trading.
- The Manitowoc Company, Inc. MTW shares dipped 6.4% to $9.12 in pre-market trading.
Now Read This:
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.